Home | Screening data | Screen comparisons | Search for compounds | Structure search

Compound InformationSONAR Target prediction
Name:

SODIUM beta-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE

Unique Identifier:SPE01503902
MolClass: Checkout models in ver1.5 and ver1.0
Molecular Formula:C21H27N7NaO17P3
Molecular Weight:738.173 g/mol
X log p:6.741  (online calculus)
Lipinksi Failures3
TPSA242.54
Hydrogen Bond Donor Count:0
Hydrogen Bond Acceptors Count:23
Rotatable Bond Count:13
Canonical Smiles:[Na+].[O-]P(O)(=O)OC1C(O)C(COP(O)(=O)OP([O-])(=O)OCC2OC(C(O)C2O)[n+]2c
ccc(c2)C(N)=O)OC1n1cnc2c(N)ncnc12
Therapeutics:cofactor in aryl & steroidal hydroxylation
Generic_name:2--MONOPHOSPHOADENOSINE 5--DIPHOSPHORIBO
Chemical_iupac_name:NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE
Drug_type:Experimental
Drugbank_id:EXPT02293
Drug_category:Aldose Reductase inhibitor
Organisms_affected:-1

Found: 101 nonactive as graph: single | with analogs [1] << Back 101
Species: 4932
Condition: YPT6
Replicates: 2
Raw OD Value: r im 0.7334±0.0046669
Normalized OD Score: sc h 1.0293±0.0179981
Z-Score: 1.0013±0.653571
p-Value: 0.366574
Z-Factor: -4.92389
Fitness Defect: 1.0036
Bioactivity Statement: Nonactive
Experimental Conditions
Library:Spectrum
Plate Number and Position:17|F2
Drug Concentration:50.00 nM
OD Absorbance:600 nm
Robot Temperature:22.80 Celcius
Date:2006-02-22 YYYY-MM-DD
Plate CH Control (+):0.04215±0.00156
Plate DMSO Control (-):0.7012499999999999±0.01719
Plate Z-Factor:0.9136
png
ps
pdf

DBLink | Rows returned: 25<< Back 1 2 3 4 5 Next >> 
445204 [(2R,3R,4R)-2-(6-aminopurin-9-yl)-5-[[[[(2R,3R,4R,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxolan-2
-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic
acid
445249 [(2R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[[[(2R,3R,4R,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxolan-2
-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic
acid
445409 [(2R,3S,5S)-2-(6-aminopurin-9-yl)-5-[[[[(2R,3S,4S,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxolan-2
-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic
acid
446011 [(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[[[(2S,3S,4S,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxola
n-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic
acid
448690 [(2S,3R,4R,5S)-2-(6-aminopurin-9-yl)-5-[[[[(2S,3S,4S,5R)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxola
n-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic
acid
448815 [(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[[[(3S,4R,5S)-5-(5-carbamoylpyridin-1-yl)-3,4-dihydroxy-oxolan-2
-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic
acid

internal high similarity DBLink | Rows returned: 2
LOPAC 00471 0.9066
SPE01500419 0.9714

active | Cluster 306 | Additional Members: 11 | Rows returned: 0
Service provided by the Mike Tyers Laboratory